Consumers Union petitions the FDA on drug safety
December 31st, 2007
Divison of Dockets Management
Food and Drug Administration
Department of Health and Human Services
5630 Fishers Lane, Room 1061
Rockville, Maryland 20852
Section 906 of the FDA Amendments Act of 2007 provides that the
Secretary of Health and Human Services shall conduct a study to determine if the [following] statement [“You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088”] required with respect to published direct-to-consumer advertisements is appropriate for inclusion in…television advertisements.
The FDAAA (P.L. 110-85) requires all print advertisements to include this statement, but this should be expanded to include TV advertisements.
Currently, it is estimated that adverse drug event reporting system catches only a small fraction of all adverse incidents of drugs.3 Adverse drug reactions are responsible for as many as 700,000 emergency room visits annually. 4 Including a toll-free number and a website to report side effects will increase the information the FDA has on drug risks and would also increase awareness to consumers.
And television drug ads run far more frequently than print ads. Consumers are repeatedly faced with TV ads, with their pictorial power, compared to what is generally a one time scan in the print media. Including this number and website in TV ads would reach far more Americans than through print ads.
The FDA has stated about MedWatch:
“The MedWatch program has four goals:
- To clarify what should and should not be reported to FDA.
- To increase awareness of serious reactions caused by drugs or medical devices.
- To make the reporting process easy.
- To give the health community regular feedback about product safety issues.
While participation in MedWatch is voluntary, FDA encourages anyone aware of a serious adverse reaction, including consumers, to make a MedWatch report.”5
Including a toll-free number and a website to report side effects would certainly help the FDA achieve the above goals and it would help encourage many more consumers to report adverse reactions with medications.
Increased reporting and use of MedWatch would help in the earlier detection and better analysis of problems. All television ads should contain information on how patients should report unusual side effects to the FDA.
We believe that pursuant to section 21 CFR 25.30(a), this petition is excluded from the requirement for an environmental impact statement.
The undersigned certifies, that, to the best knowledge and belief of the undersigned, this petition includes all information and views on which the petition relies, and that it includes representative data and information known to the petitioner which are unfavorable to the petition.
2414 West 54th St
Minneapolis, Minnesota 55410
101 Truman Ave
Yonkers, NY 10703
1Consumers Union is a nonprofit membership organization chartered in 1936 under the
laws of the State of New York to provide consumers with information, education and
counsel about goods, services, health, and personal finance. Consumers Union’s income
is solely derived from the sale of Consumer Reports and ConsumerReports.org, its other publications and from noncommercial contributions, grants and fees. In addition to reports on Consumers Union’s own product testing, Consumer Reports and ConsumerReports.org, with approximately 6.5 million combined paid circulation, regularly carry articles on health, product safety, marketplace economics and legislative, judicial and regulatory actions that affect consumer welfare. Consumers Union’s publications carry no advertising and receive no commercial support. EXPERT • INDEPENDENT • NONPROFIT®
2Matthew F. Hollon, MD., “Direct-to-Consumer Advertising: A Haphazard Approach to Health Promotion,” JAMA, April 27, 2005. Vol. 293, No. 16, p. 2032.
3 Institute of Medicine, “The Future of Drug Safety, 2006, p.53
4 Daniel S. Budnitz, MD., “National Surveillance of Emergency Department Visits for Outpatient Adverse Drug Events,” JAMA, October 18,2006. Vol. 296, No. 15 p.1863
5 John Henkel., “Medwatch: FDA’s Heads Up on Medical Product Safety,” FDA Consumer Magazine, November-December 1998.